Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthOn vs LillyDirect Foundayo

HealthOn
Graded #349

Lower grade

vs+8.100000000000001
LillyDirect Foundayo
Graded #173

Higher grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 59.1/100.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLillyDirect Foundayo +26
46
72
Dose & formulationHealthOn +5
64
59
Clinical oversightHealthOn +1
79
78
Labs & monitoringEven
52
52
FulfillmentLillyDirect Foundayo +18
62
80
Contract termsLillyDirect Foundayo +8
47
55
HealthOn · left barLillyDirect Foundayo · right bar

The numbers

MetricHealthOnLillyDirect Foundayo
WeighScore59.1/10067.2/100
GradeCC
Scorecard rank#349#173
Semaglutide$189/mo (starting dose, 12-month plan, compounded)Not disclosed
Tirzepatide$290/mo (starting dose, 12-month plan, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
HealthOn

Graded #349 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Weight-loss pricing starts at $189/mo for compounded semaglutide

Where it loses points

  • No visible LegitScript certification or PCAB accreditation
  • State availability not publicly disclosed
  • Lowest advertised prices require a 12-month plan commitment
LillyDirect Foundayo

Graded #173 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard